Cost of revenue · 2016–2025
Ionis Pharmaceuticals cost of revenue
$15.9M+41.9% · FY2025
Ionis Pharmaceuticals (IONS) reported $15.9M in cost of revenue for fiscal 2025, +41.9% year on year.
| Fiscal year | Cost of revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $15.9M | +41.9% | Open → |
| FY20242024-12-31 | $11.2M | +22.8% | Open → |
| FY20232023-12-31 | $9.1M | −35.3% | Open → |
| FY20222022-12-31 | $14.1M | +30.2% | Open → |
| FY20212021-12-31 | $10.8M | −9.2% | Open → |
| FY20202020-12-31 | $11.9M | +172.5% | Open → |
| FY20192019-12-31 | $4.4M | +140.9% | Open → |
| FY20182018-12-31 | $1.8M | +$1.8M | Open → |
| FY20172017-12-31 | $0 | $0 | Open → |
| FY20162016-12-31 | $0 | — | Open → |
Cost of revenue — Cost of revenue is the direct cost of producing what the company sold — materials, manufacturing and the labour tied to delivery. It excludes sales, marketing and administration. Revenue minus this figure is gross profit.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Cost of revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ionis Pharmaceuticals cost of revenue |url=https://companiesranked.com/en/company/ionis-pharmaceuticals/cost-of-revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ionis Pharmaceuticals cost of revenue. CompaniesRanked. https://companiesranked.com/en/company/ionis-pharmaceuticals/cost-of-revenueBibTeX
@misc{companiesranked-en-company-ionis-pharmaceuticals-cost-of-revenue-2026,
author = {{CompaniesRanked}},
title = {{Ionis Pharmaceuticals cost of revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ionis-pharmaceuticals/cost-of-revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000874015-26-000115 · February 26, 2026
{{cite web |title=Ionis Pharmaceuticals cost of revenue — 10-K (0000874015-26-000115) |url=https://www.sec.gov/Archives/edgar/data/874015/000087401526000115/form10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.